Nitisinone and Phenprocoumon: Interaction Details

Brand names
Nitisinone
OrfadinNityrHarliku
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
Share

Share this interaction

Phenprocoumon

We don't have a drug information page for Phenprocoumon because it is no longer sold in the US: the FDA lists every approved version as discontinued. Have a question about Phenprocoumon? Ask a pharmacist, free →

Nitisinone

Brand names
  • Orfadin
  • Nityr
  • Harliku

What Happens When You Take Nitisinone With Phenprocoumon

What can happen when they are taken together (rated Major)

Increased exposure and an increased risk of toxicity

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

Among 18 healthy volunteers, of nitisinone raised the of TOLBUTamide, a CYP2C9 substrate, from 547.3 mcg x hr/mL (TOLBUTamide alone) to 1264 mcg x hr/mL, a significant 2.31-fold increase.3 Because nitisinone inhibits CYP2C9, using it together with other CYP2C9 substrates may raise their exposure and lead to toxicity. When nitisinone is used concomitantly, sensitive substrates and those with narrow therapeutic indices should be given at half the usual dosage.21

The Nitisinone and Phenprocoumon Interaction, Explained

Nitisinone can raise the level of phenprocoumon in your body. Nitisinone slows down , a liver enzyme that helps clear phenprocoumon, a . When this enzyme is slowed, more of the blood thinner stays in your system, which can increase its effect and raise the chance of bleeding or easy bruising.

In a study of healthy volunteers, nitisinone more than doubled the level of another drug cleared the same way. Please keep taking both medicines as prescribed and let your pharmacist or doctor know you use both. They can adjust your phenprocoumon dose and check your blood clotting tests more closely to keep you safe.

Mechanism: Nitisinone inhibits . Phenprocoumon is a CYP2C9 (with contribution) and has a , so small exposure changes matter. It is not a , so increases effect.

  • Magnitude: In healthy volunteers (n=18), tolbutamide rose 2.31-fold (547.3 to 1264 mcg·hr/mL) with nitisinone. Not studied directly with phenprocoumon.
  • Risk: Increased exposure, supratherapeutic , bleeding.
  • Onset: Unspecified. Evidence: probable. Severity: major.
  • Management: Labeling advises halving the dose of sensitive or narrow therapeutic index CYP2C9 substrates. Individualize the dose and monitor INR closely, especially at initiation and after changes in nitisinone therapy.

See the 3 references behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Nitisinone and Phenprocoumon Interact

The likely mechanism

of -mediated by nitisinone

How Drug Interactions Work Six short figures, about a minute: how one drug can raise or lower another’s level, or add to or cancel its effect. See how it works 

How to Manage the Nitisinone and Phenprocoumon Interaction

Your care team can manage this by tailoring your doses and watching you closely.

  • Product guidance suggests that sensitive drugs, or those with a narrow safety margin like phenprocoumon, may need about half the usual dose when used with nitisinone. Your prescriber will decide what is right for you.
  • Your team may monitor you more closely, such as with clotting () checks.
  • Keep taking both medicines as prescribed. Do not change or stop either one on your own.
  • Tell your pharmacist or doctor about any unusual bruising, nosebleeds, blood in urine or stool, or prolonged bleeding.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Nitisinone or Phenprocoumon need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Literature Reports

1 report from the published literature. Each one is headed by the title of the published study it comes from.

What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.

  1. Report 1 · Study title

    Non randomized study on the potential of nitisinone to inhibit cytochrome P450 2C9, 2D6, 2E1 and the organic anion transporters OAT1 and OAT3 in health volunteers

    In healthy volunteers (n=18), the mean of TOLBUTamide, a , rose significantly from a baseline of 547.3 mcg x hr/mL without nitisinone to 1264 mcg x hr/mL when it was given together with nitisinone (mean ratio, 2.31; 90% CI, 2.11 to 2.53). A single 500 mg dose of TOLBUTamide was administered once before nitisinone was started and again on day 15 of a course of nitisinone 80 mg once daily. The of TOLBUTamide was also significantly higher with nitisinone (mean ratio, 1.16).3

Nitisinone and Phenprocoumon: Common Questions

How serious is the Nitisinone and Phenprocoumon interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How is the Nitisinone and Phenprocoumon interaction managed?

Your care team can manage this by tailoring your doses and watching you closely. Product guidance suggests that sensitive drugs, or those with a narrow safety margin like phenprocoumon, may need about half the usual dose when used with nitisinone. Your prescriber will decide what is right for you. Your team may monitor you more closely, such as with clotting () checks. Keep taking both m… Management is individual — always follow your own care team's guidance.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "probable". Good supporting evidence, though not definitively proven.

Ask About the Nitisinone and Phenprocoumon Interaction

Ask in your own words about taking Nitisinone and Phenprocoumon together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (3)

  1. Product Information: HARLIKU(TM) oral tablets, nitisinone oral tablets. Cycle Pharmaceuticals Ltd (per FDA), Boston, MA, 2025. DailyMed
  2. Product Information: ORFADIN(R) oral capsules, oral suspension, nitisinone oral capsules, oral suspension. Sobi Inc (per FDA), Waltham, MA, 2019. DailyMed
  3. Huledal G, Olsson B, Onnestam K, et al: Non randomized study on the potential of nitisinone to inhibit cytochrome P450 2C9, 2D6, 2E1 and the organic anion transporters OAT1 and OAT3 in health volunteers. Eur J Clin Pharmacol 2019; 75(3):313-320.
Was this write-up helpful?

Other Serious Interactions of Nitisinone and Phenprocoumon

Also serious with Phenprocoumon

Also serious with Nitisinone

These Medications Also Interact With Supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

With Phenprocoumon

With Nitisinone

Check everything you take with our drug–supplement interaction checker.

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, as soon as they can.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together.
  • Major Potentially serious — often needs a change or close monitoring. This interaction.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven. This interaction.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized. This interaction.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.